Compound Detail
CHEMBL401663
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC(C)(c1cc(-c2cccc(-c3ccccc3S(C)(=O)=O)c2)c2ncccc2c1)S(C)(=O)=O
Basic Information
| ChEMBL ID | CHEMBL401663 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | IGDTYSYGBPLQIY-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
479.6
MW (Da)
5.25
ALogP
5
HBA
0
HBD
81.2
PSA (Ų)
0.39
QED
1
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 8.59
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 2.6 | nM | 8.59 | Inhibition of PDE4 expressed in SF9 cells | 18207397 |
| Blood | IC50 | = | 700.0 | nM | 6.16 | Inhibition of LPS-stimulated TNFalpha release in human whole blood | 18207397 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 18207397 | 10.1016/j.bmcl.2008.01.004 | Unchecked | 1 |
| 18207397 | 10.1016/j.bmcl.2008.01.004 | Blood | 1 |
Data from ChEMBL 36 via Core Engine